Amrad and Merck in Deal to Develop New Asthma Drugs
By Business Review Editor
Pharma Deals Review: Vol 2003 Issue 38 (Table of Contents)
Published: 3 Jul-2003
DOI: 10.3833/pdr.v2003.i38.879 ISSN: 1756-7874
Section: Research & Development
Abstract
Amrad and Merck Sharp & Dohme entered into multi-year research collaboration and exclusive licensing terms for the investigation and commercialization of drug candidates with therapeutic potential for asthma and other respiratory diseases...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018